Health
Results: 5521-5532 of 8803

AscellaHealth Expands Global Leadership Team: Specialty Pharmaceutical Experts with Manufacturer and Payer Expertise Propel International Growth

ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors









